Amgen Inc 주식(AMGN)의 최신 뉴스
FTC: Amgen patent arguments a “mockery of Section 2” - Global Competition Review
Amgen stock trades near record level as Q2 2026 results and dividend underpin valuation - Ad-hoc-news.de
Amgen (AMGN) Gets A Fresh Target, Is It Fully Priced? - Yahoo Finance
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? - The Motley Fool
Is Amgen (AMGN) Fully Priced As Analysts Lift Targets After Second Quarter Results? - simplywall.st
Bank of New York Mellon Corp Sells 97,857 Shares of Amgen Inc. $AMGN - MarketBeat
The Zacks Analyst Blog Highlights Amgen, Crinetics, FBT, BBH and BBP - Yahoo Finance
AssuredPartners Investment Advisors LLC Grows Stock Holdings in Amgen Inc. $AMGN - MarketBeat
B. Metzler seel. Sohn & Co. AG Cuts Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds close to record high as Q2 2026 growth and dividend support valuation - Ad-hoc-news.de
FTC Slams Amgen's Antitrust Shield Argument At 4th Circ. - Law360
Amgen Reaches Deal To End Ex-Worker's Tobacco Fee Fight - Law360
Amgen Target of Unusually High Options Trading (NASDAQ:AMGN) - MarketBeat
AMGN Maintains Overweight Rating by Piper Sandler -- Price Targe - GuruFocus
Rare disease drug recalled in Ireland after Japan deaths - RTE.ie
Incyte: Cheaper, Growing Faster, And The Market Keeps Paying Up For Amgen - Trefis
Amgen Named to The Wall Street Journal's Inaugural 2026 Best Companies for the Future List - Amgen
Amgen stock climbs to new highs on strong Q2 2026 growth - Ad-hoc-news.de
ETFs Investing in Amgen Inc. Stocks - TradingView
Better Bet Than Amgen Stock: INCY, NBIX Deliver More - Trefis
NewEdge Wealth LLC Reduces Holdings in Amgen Inc. $AMGN - MarketBeat
Main Street Financial Solutions LLC Takes $1.66 Million Position in Amgen Inc. $AMGN - MarketBeat
Wealthfront Advisers LLC Sells 6,410 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by Great Lakes Advisors LLC - MarketBeat
Amgen Inc. $AMGN Shares Sold by Danske Bank A S - MarketBeat
First National Bank of Omaha Has $15.65 Million Stake in Amgen Inc. $AMGN - MarketBeat
Amgen Inc (AMGN) Shares Surge 4.0% -- What GF Score of 79 Tells Investors - GuruFocus
Amgen abandoning $500M+ Crohn’s collab won’t derail TScan’s pipeline strategy - Fierce Biotech
Which Drugmaker Stock Has Dominated in 2026: Merck, Pfizer, or Amgen? - 24/7 Wall St.
Amgen Inc Stock (AMGN) Moved Up by 3.19% on Aug 19: What Investors Need To Know - TradingKey
Amgen Stock Surges 3.5% as Healthcare Hits Record High - Yahoo Finance
Amgen cans its TScan partnership; Amylyx reveals $350M offering - Endpoints News
AMGEN INC : ARGUS RESEARCH RAISES TARGET PRICE TO $460 - Bitget
Argus Issues Positive Forecast for Amgen (NASDAQ:AMGN) Stock Price - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Trust Co. of Vermont Purchases New Position in Amgen Inc. $AMGN - MarketBeat
Pharma in hackers' crosshairs as Amgen breach moves to courts - The Pharma Letter
Commerzbank Aktiengesellschaft FI Acquires 14,693 Shares of Amgen Inc. $AMGN - MarketBeat
AMG National Trust Bank Has $3.57 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock extends 2026 rally as Q2 earnings beat and guidance lifted - Ad-hoc-news.de
ANTITRUST NEWS—4th Cir.: FTC: Amgen’s Enbrel patent-application deal is subject to antitrust scrutiny - vitallaw.com
TScan TherapeuticsAmgen To Terminate Research Collaboration And License Agreement With TScan TherapeuticsSEC Filing - TradingView
TScan (NASDAQ: TCRX) loses Amgen Crohn’s collaboration - Stock Titan
Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Can Amgen (NASDAQ:AMGN) Extend Its Record-High Momentum? - Kalkine Media
Amgen (NASDAQ:AMGN) Results Put Growth Back In Focus - Kalkine Media
The Bull Case For Amgen (AMGN) Could Change Following Raised 2026 Earnings Guidance And Q2 BeatLearn Why - simplywall.st
Cantor Fitzgerald raises Amgen stock price target on core portfolio strength - Investing.com India
Amgen (NASDAQ:AMGN) Reaches New 1-Year High on Analyst Upgrade - MarketBeat
Amgen stock hits all-time high at 422.49 USD - Investing.com
Amgen stock hits all-time high at 422.49 USD By Investing.com - Investing.com India
Resilient Amgen stock trades above $419 as earnings beat and 2026 guidance support momentum - AD HOC NEWS
Amgen (NASDAQ:AMGN) Given New $352.00 Price Target at Mizuho - MarketBeat
Cantor Fitzgerald Forecasts Strong Price Appreciation for Amgen (NASDAQ:AMGN) Stock - MarketBeat
AMGN Maintains by Cantor Fitzgerald -- Price Target Raised to $4 - GuruFocus
Wilkinson Global Asset Management LLC Lowers Holdings in Amgen Inc. $AMGN - MarketBeat
Russell Investments Group Ltd. Sells 37,910 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Acquired by Kinsale Capital Group Inc. - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Purchases 5,903 Shares of Amgen Inc. $AMGN - MarketBeat
Kelleher Financial Advisors Buys 2,580 Shares of Amgen Inc. $AMGN - MarketBeat
Jessica Merrill: Mid-Cap Biopharma's $1B-Plus Deal Surge Could Spawn the Next Amgen - finance.biggo.com
Global Retirement Partners LLC Takes $8.88 Million Position in Amgen Inc. $AMGN - MarketBeat
Amgen stock holds above $415 as Q2 2026 growth and guidance support valuation - AD HOC NEWS
Amgen Inc. stock outperforms competitors on strong trading day - MarketWatch
Mizuho Securities Adjusts Amgen Price Target to $352 From $303 - marketscreener.com
Amgen stock holds firm after Q2 sales raised the bar - ad-hoc-news.de
자본화:
|
볼륨(24시간):